Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer:A Prospective, Single-Arm, Phase II Study
Conditions
NSCLC · Tislelizumab · Chemotherapy · Hypofractionated Radiotherapy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Zibo Municipal Hospital, Zibo, Shandong, China